Research News

Vertex VX-880 Clinical Results Lead To Insulin-Independence

On October 3, 2023, Vertex Pharmaceuticals Incorporated presented updated results from their ongoing VX-880 Phase1/2 clinical trial at the European...

Mounjaro Shows Multiple Benefits for Type 2 Diabetes Management

During the 2022 Advanced Technologies and Treatments for Diabetes Conference (ATTD), researchers shared promising data for a new medication specifically...

Diabetes Game-Changer: A Once-Weekly Insulin

Editor’s Note: People who take insulin require consistently affordable and predictable sources of insulin at all times. If you or...

Stem Cell Therapy for Type 1 Diabetes: Patient Achieved Insulin Independence on Day 270

Editor’s Note: The news shared below is from a recent and promising clinical trial. For more information on type 1...

Dedicated to Helping People With T1D: Dr. Gary Meininger on His Life and Career with Diabetes

This content was made possible with support from Vertex Pharmaceuticals, an active partner of Beyond Type 1 at the time of...

Stem-Cell Therapy for Type 1 Diabetes Reduced Patient’s Insulin Needs by 91%

Editor’s Note: The news shared below is from a recent and promising clinical trial. For more information on type 1...